Postoperative Infections Cut Back 80% by Cefuroxime

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1986

Schlagwörter:	High Risk High Risk Patient Metronidazole Risk Patient Untreated Patient

Anmerkung:	© Adis International Ltd 1986

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 536(1986), 1 vom: Mai, Seite 13-13
Übergeordnetes Werk:	volume:536 ; year:1986 ; number:1 ; month:05 ; pages:13-13

Links:	Volltext

DOI / URN:	10.1007/BF03307244

Katalog-ID:	SPR035909587

Internformat


LEADER	01000caa a22002652 4500
001	SPR035909587
003	DE-627
005	20230519212630.0
007	cr uuu---uuuuu
008	201007s1986 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/BF03307244 \|2 doi
035			\|a (DE-627)SPR035909587
035			\|a (SPR)BF03307244-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Postoperative Infections Cut Back 80% by Cefuroxime
264		1	\|c 1986
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1986
650		4	\|a High Risk \|7 (dpeaa)DE-He213
650		4	\|a High Risk Patient \|7 (dpeaa)DE-He213
650		4	\|a Metronidazole \|7 (dpeaa)DE-He213
650		4	\|a Risk Patient \|7 (dpeaa)DE-He213
650		4	\|a Untreated Patient \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 536(1986), 1 vom: Mai, Seite 13-13 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:536 \|g year:1986 \|g number:1 \|g month:05 \|g pages:13-13
856	4	0	\|u https://dx.doi.org/10.1007/BF03307244 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 536 \|j 1986 \|e 1 \|c 05 \|h 13-13

Indexfelder

matchkey_str	article:22306056:1986----::otprtvifcinctak0
hierarchy_sort_str	1986
publishDate	1986
allfields	10.1007/BF03307244 doi (DE-627)SPR035909587 (SPR)BF03307244-e DE-627 ger DE-627 rakwb eng Postoperative Infections Cut Back 80% by Cefuroxime 1986 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1986 High Risk (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Metronidazole (dpeaa)DE-He213 Risk Patient (dpeaa)DE-He213 Untreated Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 536(1986), 1 vom: Mai, Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:536 year:1986 number:1 month:05 pages:13-13 https://dx.doi.org/10.1007/BF03307244 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 536 1986 1 05 13-13
spelling	10.1007/BF03307244 doi (DE-627)SPR035909587 (SPR)BF03307244-e DE-627 ger DE-627 rakwb eng Postoperative Infections Cut Back 80% by Cefuroxime 1986 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1986 High Risk (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Metronidazole (dpeaa)DE-He213 Risk Patient (dpeaa)DE-He213 Untreated Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 536(1986), 1 vom: Mai, Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:536 year:1986 number:1 month:05 pages:13-13 https://dx.doi.org/10.1007/BF03307244 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 536 1986 1 05 13-13
allfields_unstemmed	10.1007/BF03307244 doi (DE-627)SPR035909587 (SPR)BF03307244-e DE-627 ger DE-627 rakwb eng Postoperative Infections Cut Back 80% by Cefuroxime 1986 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1986 High Risk (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Metronidazole (dpeaa)DE-He213 Risk Patient (dpeaa)DE-He213 Untreated Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 536(1986), 1 vom: Mai, Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:536 year:1986 number:1 month:05 pages:13-13 https://dx.doi.org/10.1007/BF03307244 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 536 1986 1 05 13-13
allfieldsGer	10.1007/BF03307244 doi (DE-627)SPR035909587 (SPR)BF03307244-e DE-627 ger DE-627 rakwb eng Postoperative Infections Cut Back 80% by Cefuroxime 1986 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1986 High Risk (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Metronidazole (dpeaa)DE-He213 Risk Patient (dpeaa)DE-He213 Untreated Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 536(1986), 1 vom: Mai, Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:536 year:1986 number:1 month:05 pages:13-13 https://dx.doi.org/10.1007/BF03307244 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 536 1986 1 05 13-13
allfieldsSound	10.1007/BF03307244 doi (DE-627)SPR035909587 (SPR)BF03307244-e DE-627 ger DE-627 rakwb eng Postoperative Infections Cut Back 80% by Cefuroxime 1986 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1986 High Risk (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Metronidazole (dpeaa)DE-He213 Risk Patient (dpeaa)DE-He213 Untreated Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 536(1986), 1 vom: Mai, Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:536 year:1986 number:1 month:05 pages:13-13 https://dx.doi.org/10.1007/BF03307244 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 536 1986 1 05 13-13
language	English
source	Enthalten in Inpharma weekly 536(1986), 1 vom: Mai, Seite 13-13 volume:536 year:1986 number:1 month:05 pages:13-13
sourceStr	Enthalten in Inpharma weekly 536(1986), 1 vom: Mai, Seite 13-13 volume:536 year:1986 number:1 month:05 pages:13-13
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	High Risk High Risk Patient Metronidazole Risk Patient Untreated Patient
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1986-05-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035909587
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035909587</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519212630.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1986 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03307244</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035909587</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03307244-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Postoperative Infections Cut Back 80% by Cefuroxime</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1986</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1986</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metronidazole</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Untreated Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">536(1986), 1 vom: Mai, Seite 13-13</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:536</subfield><subfield code="g">year:1986</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:13-13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03307244</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">536</subfield><subfield code="j">1986</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">13-13</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Postoperative Infections Cut Back 80% by Cefuroxime High Risk (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Metronidazole (dpeaa)DE-He213 Risk Patient (dpeaa)DE-He213 Untreated Patient (dpeaa)DE-He213
topic	misc High Risk misc High Risk Patient misc Metronidazole misc Risk Patient misc Untreated Patient
spellingShingle	misc High Risk misc High Risk Patient misc Metronidazole misc Risk Patient misc Untreated Patient Postoperative Infections Cut Back 80% by Cefuroxime
topic_unstemmed	misc High Risk misc High Risk Patient misc Metronidazole misc Risk Patient misc Untreated Patient
topic_browse	misc High Risk misc High Risk Patient misc Metronidazole misc Risk Patient misc Untreated Patient
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Postoperative Infections Cut Back 80% by Cefuroxime
ctrlnum	(DE-627)SPR035909587 (SPR)BF03307244-e
title_full	Postoperative Infections Cut Back 80% by Cefuroxime
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1986
contenttype_str_mv	txt
container_start_page	13
container_volume	536
format_se	Elektronische Aufsätze
doi_str_mv	10.1007/BF03307244
title_sort	postoperative infections cut back 80% by cefuroxime
title_auth	Postoperative Infections Cut Back 80% by Cefuroxime
abstract	© Adis International Ltd 1986
abstractGer	© Adis International Ltd 1986
abstract_unstemmed	© Adis International Ltd 1986
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Postoperative Infections Cut Back 80% by Cefuroxime
url	https://dx.doi.org/10.1007/BF03307244
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1007/BF03307244
up_date	2024-07-03T16:06:16.178Z
_version_	1803574602554671105
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035909587</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519212630.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1986 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03307244</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035909587</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03307244-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Postoperative Infections Cut Back 80% by Cefuroxime</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1986</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1986</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metronidazole</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Untreated Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">536(1986), 1 vom: Mai, Seite 13-13</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:536</subfield><subfield code="g">year:1986</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:13-13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03307244</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">536</subfield><subfield code="j">1986</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">13-13</subfield></datafield></record></collection>
score	7.3996525

Nicht das Richtige dabei?

Schreiben Sie uns!

Postoperative Infections Cut Back 80% by Cefuroxime

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?